Advances in uterine protein research: Reproduction and cancer

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 2, 2004, Pages 105-118

  Seppala M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Contraception; Fertilization; Functional Glycomics; Glycodelin

Indexed keywords

CD4 ANTIGEN; GESTAGEN; GLYCOPROTEIN GP 120; ISOPROTEIN; LEVONORGESTREL; MEMBRANE PROTEIN; PLACENTA PROTEIN 14; PROGESTERONE;

ANALYTIC METHOD; BASEMENT MEMBRANE; BINDING SITE; CANCER CELL; CANCER STAGING; CARBOHYDRATE ANALYSIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHEMICAL MODIFICATION; COCULTURE; CONFERENCE PAPER; CONTRACEPTION; DNA TRANSFECTION; EPITHELIUM CELL; FERTILIZATION; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; LUTEAL PHASE; MORPHOGENESIS; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; NIDATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION; REPRODUCTION; SEMINAL PLASMA; SPERMATOZOON; STROMA CELL; TISSUE DISTRIBUTION; UTERUS CANCER; UTERUS FLUID; VIRUS ISOLATION; VIRUS TRANSMISSION; ZONA PELLUCIDA; ZYGOTE;

EID: 1942439784     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.01.007     Document Type: Conference Paper

References (60)

1. Kao L.C., Tulac S., Lobo S., Imani B., Yang J.P., Germeyer A., et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology. 143:2002;2119-2138.
2. Daly M.B., Ozols R.F. The search for predictive patterns in ovarian cancer: proteomics meets bioinformatics. Cancer Cell. 1:2002;111-112.
3. Wassarman P.M. Zona pellucida glycoproteins. Annu Rev Biochem. 57:1988;415-442.
4. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 52:1989;257-331.
5. Seppälä M., Taylor R.N., Koistinen H., Koistinen R., Milgrom E. Glycodelin: A major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev. 23:2002;401-430.
6. Dell A., Morris H.R., Easton R., Panico M., Patankar M., Oehninger S., et al. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem. 270:1995;24116-24126.
7. Okamoto N., Uchida A., Takakura K., Kariya Y., Kanzaki H., Riittinen L., et al. Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol. 26:1991;137-142.
8. Clark G.F., Oehninger S., Patankar M.S., Koistinen R., Dell A., Morris H.R., et al. A role for glycoconjugates in human development: the human feto-embryonic defense system hypothesis. Hum Reprod. 11:1996;467-473.
9. Gao J., Mazella J., Seppala M., Tseng L. Ligand activated HPR modulates the glycodelin promoter activity through the SP1 sites in human endometrial adenocarcinoma cells. Mol Cell Endocrinol. 176:2001;97-102.
10. Taylor R.N., Savouret J.-F., Vaisse C., Vigne J.-L., Ryan I., Hornung D., et al. Promegestone (R5020) and Mifepristone (RU486) both function as progestational agonists of human glycodelin gene expression in isolated human epithelial cells. J Clin Endocrinol Metab. 83:1998;4006-4012.
11. Tseng L., Zhu H.H., Mazella J., Koistinen H., Seppälä M. Relaxin stimulates glycodelin mRNA and protein concentrations in human endometrial glandular epithelial cells. Mol Hum Reprod. 5:1999;372-375.
12. Li T.C., Ling E., Dalton C., Bolton A.E., Cooke I.D. Concentration of endometrial protein PP14 in uterine flushings throughout the menstrual cycle in normal, fertile women. Br J Obstet Gynaecol. 100:1993;460-464.
13. Julkunen M., Koistinen R., Sjöberg J., Rutanen E.M., Wahlström T., Seppälä M. Secretory endometrium synthesizes placental protein 14. Endocrinology. 118:1986;1782-1786.
14. Julkunen M., Apter D., Seppälä M., Stenman U.H., Bohn H. Serum levels of placental protein 14 reflect ovulation in nonconceptional menstrual cycles. Fertil Steril. 45:1986;47-50.
15. Chatzaki E., Gallaher C.J., Iles R.K., Ind T.E., Nouri A.M., Bax C.M., et al. Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium. Br J Cancer. 69:1994;1010-1014.
16. Julkunen M., Rutanen E.M., Koskimies A.I., Ranta T., Bohn H., Seppälä M. Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol. 92:1985;1145-1151.
17. Koistinen H., Easton R.L., Koistinen R., Chiu P.C.N., Chalabi S., Halttunen M., et al. Differences in glycosylation and sperm-egg binding inhibition of pregnancy-related glycodelin. Biol Reprod. 69:2003;1545-1551.
18. Koninckx P.R., Riittinen L., Seppälä M., Cornillie F.J. CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis. Fertil Steril. 57:1992;523-530.
19. Coddington C.C., Oehninger S., Cunningham D.S., Hansen K., Sueldo C., Hodgen G.D. Peritoneal fluid from patients with endometriosis decreases sperm binding to the zona pellucida in the hemizona assay: a preliminary report. Fertil Steril. 57:1992;783-786.
20. Oehninger S., Coddington C.C., Hodgen G.D., Seppälä M. Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril. 63:1995;377-383.
21. Burkman L.J., Coddington C.C., Franken D.R., Krugen T.F., Rosenwaks Z., Hodgen G.D. The hemizona assay (HZA): development of a diagnostic test for the binding of human spermatozoa to the human hemizona pellucida to predict fertilization potential. Fertil Steril. 49:1988;688-697.
22. Julkunen M., Wahlström T., Seppälä M., Koistinen R., Koskimies A., Stenman U.H., et al. Detection and localization of placental protein 14-like protein in human seminal plasma and in the male genital tract. Arch Androl. 12:(Suppl):1984;59-67.
23. Koistinen H., Koistinen R., Dell A., Morris H.R., Easton R.L., Patankar M.S., et al. Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Mol Hum Reprod. 2:1996;759-765.
24. Morris H.R., Dell A., Easton R.L., Panico M., Koistinen H., Koistinen R., et al. Gender specific glycosylation of human glycodelin affects contraceptive activity. J Biol Chem. 271:1996;32159-32167.
25. Riittinen L., Närvänen O., Virtanen I., Seppälä M. Monoclonal antibodies against endometrial protein PP14 and their use for purification and radioimmunoassay of PP14. J Immunol Methods. 136:1991;85-90.
26. Yao Y.Q., Yeung W.S., Ho P.C. Human follicular fluid inhibits the binding of human spermatozoa to zona pellucida in vitro. Hum Reprod. 11:1996;2674-2680.
27. Seppälä M., Koskimies A.I., Tenhunen A., Rutanen E.M., Sjöberg J., Koistinen R., et al. Pregnancy proteins in seminal plasma, seminal vesicles, preovulatory follicular fluid and ovary. Ann NY Acad Sci. 442:1985;212-216.
28. Chiu P.C.N., Koistinen R., Koistinen H., Seppala M., Lee K.F., Yeung W.S.B. Binding of zona binding inhibitory factor-1 (ZIF-1) from human follicular fluid on spermatozoa. J Biol Chem. 278:2003;13570-13577.
29. Chiu P.C.N., Koistinen R., Koistinen H., Seppälä M., Lee K.F., Yeung W.S.B. Zona binding inhibitory factor-1 from human follicular fluid is an isoform of glycodelin. Biol Reprod. 69:2003;365-372.
30. Tse J.Y.M., Chiu P.C.N., Lee K.F., Seppala M., Koistinen H., Koistinen R., Yao Y.Q., et al. The synthesis and fate of glycodelin in human ovary during folliculogenesis. Mol Hum Reprod. 8:2002;142-148.
31. Wilcox A.J., Weinberg C.R., Baird D.D. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med. 333:1995;1517-1521.
32. Telimaa S., Kauppila A., Rönnberg L., Suikkari A.-M, Seppälä M. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate. Am J Obstet Gynecol. 161:1989;866-871.
33. Mandelin E., Koistinen H., Koistinen R., Arola J., Affandi B., Seppälä M. Endometrial expression of glycodelin in levonorgestrel-releasing subdermal implant wearing women. Fertil Steril. 76:2001;474-478.
34. Mandelin E., Koistinen H., Koistinen R., Affandi B., Seppälä M. Levonorgestrel-releasing IUD-wearing women express contraceptive glycodelin-A in endometrium during midcycle: another contraceptive mechanism? Hum Reprod. 12:1997;2671-2675.
35. Neurath A.R., Jiang S., Strick N., Lin K., Li Y.-Y., Debnath A.K. Bovine β-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV. Nature Med. 2:1996;230-234.
36. Seppälä M., Jiang S., Strick N., Lin K., Li Y.-Y., Koistinen H., et al. Glycodelins GdA and GdS modified by 3-hydroxyphthalic anhydride inhibit gp120-CD4 binding and HIV-1 infection in vitro. Lab Invest. 77:1997;127-130.
37. Van den Nieuwenhof I.M., Koistinen H., Easton R.L., Koistinen R., Kämäräinen M., Morris H.R., et al. Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in Chinese hamster ovary cells. Eur J Biochem. 267:2000;4753-4762.
38. Damario M.A., Lesnick T.G., Lessey B.A., Kowalik A., Mandelin E., Seppälä M., et al. Endometrial markers of uterine receptivity utilizing the donor oocyte model. Hum Reprod. 16:2001;1893-1899.
39. Seppälä M., Lessey B.A. Determination of endometrial status and the implantation window. Van Blerkom J., Gregory L. Essential IVF. 2003;577-609 Kluwer Academic Publishers, Boston.
40. King A., Burrows T., Loke Y.W. Human uterine natural killer cells. Nat Immunol. 15:1996;41-52.
41. Varki A. Selectin ligands. Proc Natl Acad Sci USA. 91:1994;7390-7397.
42. Genbacev O.D., Prakobpol A., Foulk R.A., Krtolica A.R., Ilic D., Singer M.S., et al. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science. 299:2003;355-356.
43. Rachmilewitz J., Riely G.J., Tykocinski M.L. Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol. 191:1999;26-33.
44. Rachmilewitz J., Borovsky Z., Mishan-Eisenberg G., Yaniv E., Riely G.J., Tykocinski M.L. Focal localization of placental protein 14 toward sites of TCR engagement. J Immunol. 168:2002;2745-2750.
45. Mukhopadhyay D., Sundereshan S., Rao C., Karande A.A. Placental protein 14 (PP14) induces apoptosis in T cells, but not in monocytes. J Biol Chem. 276:2001;28268-28273.
46. Jakubowicz D.J., Seppälä M., Jakubowicz S., Rodriguez-Armars O., Rivas-Santiago A., Koistinen H., et al. Insulin reduction with metformin increases luteal-phase serum glycodelin and insulin-like growth factor binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab. 86:2001;1126-1133.
47. Mackenna A., Li T.C., Dalton C., Bolton A., Cooke I. Placental protein 14 levels in uterine flushing and plasma of women with unexplained infertility. Fertil Steril. 59:1993;577-582.
48. Dalton C.F., Laird S.M., Estdale S.E., Saravelos H.G., Li T.C. Endometrial protein PP14 and CA-125 in recurrent miscarriage patients: Correlation with pregnancy outcome. Hum Reprod. 13:1998;3197-3202.
49. Tulppala M., Julkunen M., Tiitinen A., Stenman U.-H., Seppälä M. Habitual abortion is accompanied by low serum levels of placental protein 14 in the luteal phase of the fertile cycle. Fertil Steril. 63:1995;792-795.
50. Jakubowicz D.J., Essah P.A., Seppälä M., Jakubowicz S., Koistinen R., Nestler J.E. Reduced glycodelin and insulin-like growth factor-binding protein 1 in women with polycystic ovary syndrome during first trimester of pregnancy'. J Clin Endocrinol Metab. 89:2004;833-839.
51. Arnold J.T., Lessey B.A., Seppälä M., Kaufman D.G. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res. 62:2002;79-88.
52. Kämäräinen M., Seppälä M., Virtanen I., Andersson L.C. Expression of glycodelin in MCF-7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest. 77:1997;565-573.
53. Riittinen L. Serous ovarian cyst fluids contain high levels of endometrial protein PP14. Tumor Biol. 13:1992;175-179.
54. Mandelin E., Lassus H., Seppälä M., Leminen A., Gustafsson J.-Å., Cheng G., et al. Glycodelin in ovarian serous carcinoma: Association with differentiation and survival. Cancer Res. 63:2003;6258-6264.
55. Julkunen M., Seppälä M., Jänne O.A. Complete amino acid sequence of human placental protein 14: A progestogerone-regulated uterine protein homologous to β-lactoglobulins. Proc Natl Acad Sci USA. 85:1988;8845-8849.
56. Kämäräinen M., Julkunen M., Seppälä M. HinfI polymorphism in the human progesterone associated endometrial protein (PAEP) gene. Nucleic Acids Res. 19:1991;5092.
57. Koistinen H., Koistinen R., Hydén-Granskog C., Øystein M., Seppälä M. Seminal plasma glycodelin and fertilization in vitro. J Androl. 21:2000;636-640.
58. Gemzell Danielsson K., Westlund P., Johannisson E., Swahn M.-L., Bygdeman M., Seppälä M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum Reprod. 11:1996;256-264.
59. Vaisse C., Atger M., Potier B., Milgrom E. Human placental protein 14 gene: sequence and characterization of a short duplication. DNA Cell Biol. 9:1990;401-413.
60. Koistinen H., Koistinen R., Seppälä M., Burova T.V., Choiset Y., Hærtlé T. Glycodelin and β-lactoglobulin, lipocalins with high structural similarity, differ in ligand binding properties. FEBS Lett. 450:1999;158-162.